The global live cell Imaging market is projected to reach USD 4.3 billion by 2028 from USD 2.7 billion in 2023, at a CAGR of 10.2% during the forecast period of 2023 to 2028. The growth of this market is majorly driven by growing adoption of high-content screening techniques in drug discovery.

To know about the assumptions considered for the study download the pdf brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163914483

Live cell imaging is an essential tool in high-content screening (HCS), allowing researchers to observe and track cellular responses in real-time. High-resolution imaging can provide valuable information on the structure and function of cells, as well as the effects of potential drug compounds.

Key Market Players

The global market is a consolidated market, with Danaher (US), ZEISS Group (Germany), Thermo Fisher Scientific, Inc. (US), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), and  Sartorius AG (Germany) together accounting for ~75–85% of the global market.

Danaher (US)

Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services. Its business consists of four segments: Biotechnology, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences business offers a broad range of research tools and provides solutions for five key subsegments: Flow Cytometry, Genomics, Lab Automation, Centrifugation, Particle Counting and Characterization, Mass Spectrometry, Microscopy, Industrial Filtration, and Genomic Consumables. Live cell imaging solutions fall under the Microscopy subsegment. The company’s live cell imaging products are provided by two subsidiaries: Molecular Devices LLC (US) and Leica Microsystems CMS GmbH (Germany).

Access Complete Report along with TOC @ https://www.marketsandmarkets.com/Market-Reports/live-cell-imaging-market-163914483.html

ZEISS Group (Germany)

ZEISS Group operates in the fields of optics and optoelectronics. Carl Zeiss AG is the strategic management holding company that manages the ZEISS Group. The company operates its business through five segments: Semiconductor Manufacturing Technology, Industrial Quality and Research, Medical Technology, Consumer Markets, and Others. The Industrial Quality and Research segment provides industrial quality solutions and research microscopy solutions.

Sartorius AG (Germany)

Sartorius AG is an international pharmaceutical and laboratory equipment supplier. The company has two primary business segments: Bioprocess Solutions and Lab Products & Services. The Lab Products & Services division offers laboratory balances, pipettes, and laboratory consumables, among others. Live cell imaging products are offered mainly by the Lab Products & Services division of the company.

Recent Developments

• In February 2023, Nikon Corporation launched the Nikon Spatial Array Confocal (NSPARC) detector for AX systems. This detector enables high-resolution imaging of live tissue with minimal phototoxicity.
• In January 2022, CytoSMART Technologies launched Omni Pro 12, adding to the Omni live cell imaging product portfolio.

Make an Enquire to Buy this Research Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=163914483

Read More @ https://www.prnewswire.com/news-releases/live-cell-imaging-market-worth-4-3-billion–marketsandmarkets-301837149.html

sContact:

Mr. Aashish Mehra

MarketsandMarkets INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

[email protected]

The post Live Cell Imaging Market Analysis, Revenue Share, Company Profiles, Launches, & Forecast Till 2028 appeared first on MarketsandMarkets Blog.